UncategorizedKDx Diagnostics And Lister Hospital Announce The Launch Of A Non-Invasive URO17® Urine Test For Bladder Cancer In The United KingdomDecember 7, 20210
Bladder CancerSBU’s Ken Shroyer shows protein serves as marker of bladder, pancreatic cancersJune 27, 2021
UncategorizedKDx Diagnostics, Cardiff University, Cardiff and Vale University Health Board and Cellpath announceJune 3, 20210
Uncategorized07/03/20 KDx Diagnostics Announces CE Marking for Innovative Non-invasive URO17™ Bladder Cancer TestJuly 26, 20200
Uncategorized01/08/20 KDx Diagnostics announces FDA Breakthrough Device designation for URO17™, Innovative urineJanuary 8, 20200
UncategorizedDemonstration of Keratin 17 Biomarker for Urothelial Carcinoma DetectionNovember 3, 20190